Q4 2019 Ligand Pharmaceuticals Inc Earnings Call Transcript
' -
Welcome to Ligand's Fourth Quarter and Full Year 2019 Financial Results and Business Update Conference Call. Speaking today for Ligand are John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO. We will be using slides to guide our discussion today that are located on our website under the IR calendar section of the website, I know it's not easy to find, we're working on fixing that, but for today, that's where you'll be able to get to them.
We will also be using non-GAAP financial measures and some of our statements will be forward-looking. Additional information concerning risk factors and other matters concerning Ligand can be found in our Ligand's earnings press release, the slides associated with today's call and our periodic filings with the SEC.
Ligand undertakes no obligation to revise or update any statements to reflect events or circumstances after the date of this conference call.
I will now turn the call over to John Higgins.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |